Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC51H69N7O10S |
InChIKeyLIMCHOLAKDUZDS-XARBDFOFSA-N |
CAS Registry2362575-45-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | DE | 05 Feb 2019 |